Pharma companies investing in mobile phone apps for tracking diabetes

 

taking control

 

Pharma giants Merck and Novartis have increased their investment in mobile phone applications and educational websites, it has emerged.

A report by consultancy Ernst and Young revealed that the two companies have spent 78 per cent more on apps in an attempt to convince patients they should take their drug treatments, as well as eating properly and taking exercise .

It was also found that pharmaceutical firms started 97 different projects for using information technology to benefit patient health in 2010, as compared to the 124 projects that had been initiated in the four years before that. It was shown that around 41 per cent of these projects were for applications on smartphones, which was a rise of 11 per cent from 2006.

Drug manufacturers are now taking more responsibility for ensuring patients are successfully taking their treatments, especially with increased pressure to prove that their drugs are value for money.

Among the applications developed for the iPhone are an app for learning about diabetes and the tracking of levels of blood glucose, nutrition, and activity, one that provides the opportunity to maintain a record of your vaccinations, and a German language map that allows you to pinpoint locations of diabetes specialists.

Sourse: Pharma companies investing in mobile phone apps for tracking diabetes.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s